Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

OBJECTIVE: To determine whether treatment with recombinant human thrombomodulin (rhTM) increases survival among patients with severe septic-induced disseminated intravascular coagulation (DIC). DESIGN: Single-centre, open-label, randomised controlled trial. SETTING: Single tertiary hospital. PARTICI...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:BMJ Open
मुख्य लेखकों: Hagiwara, Akiyoshi, Tanaka, Noriko, Uemura, Tatsuki, Matsuda, Wataru, Kimura, Akio
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMJ Publishing Group 2016
विषय:
Intensive Care
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5223629/
https://ncbi.nlm.nih.gov/pubmed/28039291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-012850
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन